FAM110A and mesothelioma: High expression of FAM110 was significantly associated with poorer prognosis in patients with adrenocortical carcinoma (ACC), BLCA, BRCA, COAD, ESCA, KIRC, LAML, LIHC, LUSC, mesothelioma (MESO), OV, and UVM, with LIHC showing the most significant association with FAM110A.